Blepharitis

May 18, 2020

Sight Sciences Announces Positive Clinical Results from Randomized, Controlled Trial of TearCare for the Treatment of Dry Eye Disease

Mar 02, 2020

Eyevance Pharmaceuticals launches TOBRADEX® ST in the United States

Mar 02, 2020

Eyevance Pharmaceuticals launches TOBRADEX® ST in the United States

Jan 08, 2020

Tarsus Pharmaceuticals Raises $60 Million in Series B Financing

Oct 16, 2019

Eyevance Pharmaceuticals Acquires TOBRADEX® ST and NATACYN®

Oct 12, 2019

A Simple Step-by-Step Approach to Optimize Lid Hygiene

Sep 19, 2019

Myco Industries, Inc. Announces U.S. Patent and Trademark Office has issued U.S. Patent No. 10,404203 for the AB Max(TM)

May 08, 2019

The Relief Products(TM) Introduces New PM Ointments to Support Nighttime Healing and Recuperative Sleep

Apr 30, 2019

Sight Sciences Announces Official Launches of TearCare® and the Enhanced, Next Generation OMNI® System

Feb 20, 2019

Bruder Introduces Hygienic Eyelid Solution

Oct 24, 2017

Imprimis Launches Surface Pharmaceuticals Subsidiary